GSK EPS - Earnings per Share 2010-2023 | GSK
GSK annual and quarterly earnings per share history from 2010 to 2023. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- GSK EPS for the quarter ending March 31, 2023 was $0.89, a 26.33% decline year-over-year.
- GSK EPS for the twelve months ending March 31, 2023 was $8.74, a 151.16% increase year-over-year.
- GSK 2022 annual EPS was $9.06, a 200.9% increase from 2021.
- GSK 2021 annual EPS was $3.01, a 17.8% decline from 2020.
- GSK 2020 annual EPS was $3.66, a 23.96% increase from 2019.
| GSK Annual EPS |
| 2022 |
$9.06 |
| 2021 |
$3.01 |
| 2020 |
$3.66 |
| 2019 |
$2.96 |
| 2018 |
$2.43 |
| 2017 |
$1.00 |
| 2016 |
$0.63 |
| 2015 |
$6.59 |
| 2014 |
$2.14 |
| 2013 |
$4.34 |
| 2012 |
$3.69 |
| 2011 |
$4.06 |
| 2010 |
$1.29 |
| 2009 |
$4.23 |
| GSK Quarterly EPS |
| 2023-03-31 |
$0.89 |
| 2022-12-31 |
$1.50 |
| 2022-09-30 |
$5.94 |
| 2022-06-30 |
$0.41 |
| 2022-03-31 |
$1.20 |
| 2021-12-31 |
$0.51 |
| 2021-09-30 |
$0.80 |
| 2021-06-30 |
$0.98 |
| 2021-03-31 |
$0.73 |
| 2020-12-31 |
$0.47 |
| 2020-09-30 |
$0.80 |
| 2020-06-30 |
$1.40 |
| 2020-03-31 |
$1.00 |
| 2019-12-31 |
$0.84 |
| 2019-09-30 |
$0.96 |
| 2019-06-30 |
$0.62 |
| 2019-03-31 |
$0.54 |
| 2018-12-31 |
$0.82 |
| 2018-09-30 |
$0.93 |
| 2018-06-30 |
$0.30 |
| 2018-03-31 |
$0.39 |
| 2017-12-31 |
$-0.35 |
| 2017-09-30 |
$0.80 |
| 2017-06-30 |
$-0.12 |
| 2017-03-31 |
$0.66 |
| 2016-12-31 |
$0.17 |
| 2016-09-30 |
$0.54 |
| 2016-06-30 |
$-0.32 |
| 2016-03-31 |
$0.21 |
| 2015-12-31 |
$-0.28 |
| 2015-09-30 |
$0.43 |
| 2015-06-30 |
$0.11 |
| 2015-03-31 |
$6.30 |
| 2014-12-31 |
$0.80 |
| 2014-09-30 |
$0.34 |
| 2014-06-30 |
$0.58 |
| 2014-03-31 |
$0.58 |
| 2013-12-31 |
$2.05 |
| 2013-09-30 |
$0.80 |
| 2013-06-30 |
$0.81 |
| 2013-03-31 |
$0.76 |
| 2012-12-31 |
$0.71 |
| 2012-09-30 |
$0.91 |
| 2012-06-30 |
$0.99 |
| 2012-03-31 |
$1.06 |
| 2011-12-31 |
$0.98 |
| 2011-09-30 |
$1.08 |
| 2011-06-30 |
$0.88 |
| 2011-03-31 |
$1.19 |
| 2010-12-31 |
$-0.54 |
| 2010-09-30 |
$0.98 |
| 2010-06-30 |
$-0.23 |
| 2010-03-31 |
$1.00 |
| 2009-12-31 |
$1.30 |
| 2009-09-30 |
$1.08 |
| 2009-06-30 |
$1.16 |
| 2009-03-31 |
$0.80 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$69.839B |
$36.279B |
|
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
|
